Cargando…

Obesity hormone leptin: a new target in breast cancer?

Leptin is a multifunctional hormone produced mainly by the adipose tissue and involved in the regulation of food intake and energy balance. In addition, leptin can stimulate mitogenic and angiogenic processes in peripheral organs. Because leptin levels are elevated in obese individuals and excess bo...

Descripción completa

Detalles Bibliográficos
Autor principal: Surmacz, Eva
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851379/
https://www.ncbi.nlm.nih.gov/pubmed/17274833
http://dx.doi.org/10.1186/bcr1638
_version_ 1782132962057256960
author Surmacz, Eva
author_facet Surmacz, Eva
author_sort Surmacz, Eva
collection PubMed
description Leptin is a multifunctional hormone produced mainly by the adipose tissue and involved in the regulation of food intake and energy balance. In addition, leptin can stimulate mitogenic and angiogenic processes in peripheral organs. Because leptin levels are elevated in obese individuals and excess body weight has been shown to increase breast cancer risk in postmenopausal women, attempts have been made to evaluate whether leptin can promote breast cancer. Data obtained in cell and animal models and analyses of human breast cancer biopsies indeed suggest such an involvement. Furthermore, a recent report clearly shows that targeting leptin signaling may reduce mammary carcinogenesis. Thus, leptin should become a new attractive target in breast cancer.
format Text
id pubmed-1851379
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18513792007-04-12 Obesity hormone leptin: a new target in breast cancer? Surmacz, Eva Breast Cancer Res Viewpoint Leptin is a multifunctional hormone produced mainly by the adipose tissue and involved in the regulation of food intake and energy balance. In addition, leptin can stimulate mitogenic and angiogenic processes in peripheral organs. Because leptin levels are elevated in obese individuals and excess body weight has been shown to increase breast cancer risk in postmenopausal women, attempts have been made to evaluate whether leptin can promote breast cancer. Data obtained in cell and animal models and analyses of human breast cancer biopsies indeed suggest such an involvement. Furthermore, a recent report clearly shows that targeting leptin signaling may reduce mammary carcinogenesis. Thus, leptin should become a new attractive target in breast cancer. BioMed Central 2007 2007-01-26 /pmc/articles/PMC1851379/ /pubmed/17274833 http://dx.doi.org/10.1186/bcr1638 Text en Copyright © 2007 BioMed Central Ltd
spellingShingle Viewpoint
Surmacz, Eva
Obesity hormone leptin: a new target in breast cancer?
title Obesity hormone leptin: a new target in breast cancer?
title_full Obesity hormone leptin: a new target in breast cancer?
title_fullStr Obesity hormone leptin: a new target in breast cancer?
title_full_unstemmed Obesity hormone leptin: a new target in breast cancer?
title_short Obesity hormone leptin: a new target in breast cancer?
title_sort obesity hormone leptin: a new target in breast cancer?
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851379/
https://www.ncbi.nlm.nih.gov/pubmed/17274833
http://dx.doi.org/10.1186/bcr1638
work_keys_str_mv AT surmaczeva obesityhormoneleptinanewtargetinbreastcancer